+1 347 708 0418
The Clinical Next-Generation Sequencing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Clinical Next-Generation Sequencing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Clinical Next-Generation Sequencing market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Clinical Next-Generation Sequencing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Targeted Sequencing
Exome Sequencing
Others
Market segment by Application, can be divided into
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
Market segment by players, this report covers
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Clinical Next-Generation Sequencing
1.2 Classification of Clinical Next-Generation Sequencing by Type
1.2.1 Overview: Global Clinical Next-Generation Sequencing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Type in 2020
1.2.3 Targeted Sequencing
1.2.4 Exome Sequencing
1.2.5 Others
1.3 Global Clinical Next-Generation Sequencing Market by Application
1.3.1 Overview: Global Clinical Next-Generation Sequencing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Global Clinical Next-Generation Sequencing Market Size & Forecast
1.5 Global Clinical Next-Generation Sequencing Market Size and Forecast by Region
1.5.1 Global Clinical Next-Generation Sequencing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Clinical Next-Generation Sequencing Market Size by Region, (2016-2021)
1.5.3 North America Clinical Next-Generation Sequencing Market Size and Prospect (2016-2026)
1.5.4 Europe Clinical Next-Generation Sequencing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Clinical Next-Generation Sequencing Market Size and Prospect (2016-2026)
1.5.6 South America Clinical Next-Generation Sequencing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Clinical Next-Generation Sequencing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Clinical Next-Generation Sequencing Market Drivers
1.6.2 Clinical Next-Generation Sequencing Market Restraints
1.6.3 Clinical Next-Generation Sequencing Trends Analysis
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Product and Solutions
2.1.4 Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 PerkinElmer
2.2.1 PerkinElmer Details
2.2.2 PerkinElmer Major Business
2.2.3 PerkinElmer Clinical Next-Generation Sequencing Product and Solutions
2.2.4 PerkinElmer Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 PerkinElmer Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Clinical Next-Generation Sequencing Product and Solutions
2.3.4 Illumina Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Clinical Next-Generation Sequencing Product and Solutions
2.4.4 Beckman Coulter Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 GATC Biotech
2.5.1 GATC Biotech Details
2.5.2 GATC Biotech Major Business
2.5.3 GATC Biotech Clinical Next-Generation Sequencing Product and Solutions
2.5.4 GATC Biotech Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GATC Biotech Recent Developments and Future Plans
2.6 Qiagen
2.6.1 Qiagen Details
2.6.2 Qiagen Major Business
2.6.3 Qiagen Clinical Next-Generation Sequencing Product and Solutions
2.6.4 Qiagen Clinical Next-Generation Sequencing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Qiagen Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Clinical Next-Generation Sequencing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Clinical Next-Generation Sequencing Players Market Share
3.2.2 Top 10 Clinical Next-Generation Sequencing Players Market Share
3.2.3 Market Competition Trend
3.3 Clinical Next-Generation Sequencing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Clinical Next-Generation Sequencing Revenue and Market Share by Type (2016-2021)
4.2 Global Clinical Next-Generation Sequencing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2016-2021)
5.2 Clinical Next-Generation Sequencing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Clinical Next-Generation Sequencing Revenue by Type (2016-2026)
6.2 North America Clinical Next-Generation Sequencing Revenue by Application (2016-2026)
6.3 North America Clinical Next-Generation Sequencing Market Size by Country
6.3.1 North America Clinical Next-Generation Sequencing Revenue by Country (2016-2026)
6.3.2 United States Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
6.3.3 Canada Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
6.3.4 Mexico Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Clinical Next-Generation Sequencing Revenue by Type (2016-2026)
7.2 Europe Clinical Next-Generation Sequencing Revenue by Application (2016-2026)
7.3 Europe Clinical Next-Generation Sequencing Market Size by Country
7.3.1 Europe Clinical Next-Generation Sequencing Revenue by Country (2016-2026)
7.3.2 Germany Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
7.3.3 France Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
7.3.5 Russia Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
7.3.6 Italy Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Type (2016-2026)
8.2 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Application (2016-2026)
8.3 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region
8.3.1 Asia-Pacific Clinical Next-Generation Sequencing Revenue by Region (2016-2026)
8.3.2 China Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
8.3.3 Japan Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
8.3.4 South Korea Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
8.3.5 India Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
8.3.7 Australia Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Clinical Next-Generation Sequencing Revenue by Type (2016-2026)
9.2 South America Clinical Next-Generation Sequencing Revenue by Application (2016-2026)
9.3 South America Clinical Next-Generation Sequencing Market Size by Country
9.3.1 South America Clinical Next-Generation Sequencing Revenue by Country (2016-2026)
9.3.2 Brazil Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
9.3.3 Argentina Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Clinical Next-Generation Sequencing Revenue by Type (2016-2026)
10.2 Middle East & Africa Clinical Next-Generation Sequencing Revenue by Application (2016-2026)
10.3 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country
10.3.1 Middle East & Africa Clinical Next-Generation Sequencing Revenue by Country (2016-2026)
10.3.2 Turkey Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
10.3.4 UAE Clinical Next-Generation Sequencing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Clinical Next-Generation Sequencing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Clinical Next-Generation Sequencing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Clinical Next-Generation Sequencing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Clinical Next-Generation Sequencing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Clinical Next-Generation Sequencing Revenue Market Share by Region (2021-2026)
Table 6. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Thermo Fisher Scientific Major Business
Table 8. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product and Solutions
Table 9. Thermo Fisher Scientific Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 11. PerkinElmer Major Business
Table 12. PerkinElmer Clinical Next-Generation Sequencing Product and Solutions
Table 13. PerkinElmer Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Illumina Corporate Information, Head Office, and Major Competitors
Table 15. Illumina Major Business
Table 16. Illumina Clinical Next-Generation Sequencing Product and Solutions
Table 17. Illumina Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter Major Business
Table 20. Beckman Coulter Clinical Next-Generation Sequencing Product and Solutions
Table 21. Beckman Coulter Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GATC Biotech Corporate Information, Head Office, and Major Competitors
Table 23. GATC Biotech Major Business
Table 24. GATC Biotech Clinical Next-Generation Sequencing Product and Solutions
Table 25. GATC Biotech Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Qiagen Corporate Information, Head Office, and Major Competitors
Table 27. Qiagen Major Business
Table 28. Qiagen Clinical Next-Generation Sequencing Product and Solutions
Table 29. Qiagen Clinical Next-Generation Sequencing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Global Clinical Next-Generation Sequencing Revenue (USD Million) by Players (2019-2021)
Table 31. Global Clinical Next-Generation Sequencing Revenue Share by Players (2019-2021)
Table 32. Breakdown of Clinical Next-Generation Sequencing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 33. Clinical Next-Generation Sequencing Players Head Office, Products and Services Provided
Table 34. Clinical Next-Generation Sequencing Mergers & Acquisitions in the Past Five Years
Table 35. Clinical Next-Generation Sequencing New Entrants and Expansion Plans
Table 36. Global Clinical Next-Generation Sequencing Revenue (USD Million) by Type (2016-2021)
Table 37. Global Clinical Next-Generation Sequencing Revenue Share by Type (2016-2021)
Table 38. Global Clinical Next-Generation Sequencing Revenue Forecast by Type (2021-2026)
Table 39. Global Clinical Next-Generation Sequencing Revenue by Application (2016-2021)
Table 40. Global Clinical Next-Generation Sequencing Revenue Forecast by Application (2021-2026)
Table 41. North America Clinical Next-Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 42. North America Clinical Next-Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 43. North America Clinical Next-Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 44. North America Clinical Next-Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 45. North America Clinical Next-Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 46. North America Clinical Next-Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 47. Europe Clinical Next-Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 48. Europe Clinical Next-Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 49. Europe Clinical Next-Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 50. Europe Clinical Next-Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 51. Europe Clinical Next-Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 52. Europe Clinical Next-Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 53. Asia-Pacific Clinical Next-Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 54. Asia-Pacific Clinical Next-Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 55. Asia-Pacific Clinical Next-Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 56. Asia-Pacific Clinical Next-Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 57. Asia-Pacific Clinical Next-Generation Sequencing Revenue by Region (2016-2021) & (USD Million)
Table 58. Asia-Pacific Clinical Next-Generation Sequencing Revenue by Region (2021-2026) & (USD Million)
Table 59. South America Clinical Next-Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 60. South America Clinical Next-Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 61. South America Clinical Next-Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 62. South America Clinical Next-Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 63. South America Clinical Next-Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 64. South America Clinical Next-Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
Table 65. Middle East & Africa Clinical Next-Generation Sequencing Revenue by Type (2016-2021) & (USD Million)
Table 66. Middle East & Africa Clinical Next-Generation Sequencing Revenue by Type (2021-2026) & (USD Million)
Table 67. Middle East & Africa Clinical Next-Generation Sequencing Revenue by Application (2016-2021) & (USD Million)
Table 68. Middle East & Africa Clinical Next-Generation Sequencing Revenue by Application (2021-2026) & (USD Million)
Table 69. Middle East & Africa Clinical Next-Generation Sequencing Revenue by Country (2016-2021) & (USD Million)
Table 70. Middle East & Africa Clinical Next-Generation Sequencing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Clinical Next-Generation Sequencing Picture
Figure 2. Global Clinical Next-Generation Sequencing Revenue Market Share by Type in 2020
Figure 3. Targeted Sequencing
Figure 4. Exome Sequencing
Figure 5. Others
Figure 6. Clinical Next-Generation Sequencing Revenue Market Share by Application in 2020
Figure 7. Hospitals and Clinics Picture
Figure 8. Biopharma Companies Picture
Figure 9. Academic and Research Organizations Picture
Figure 10. Others Picture
Figure 11. Global Clinical Next-Generation Sequencing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Clinical Next-Generation Sequencing Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Clinical Next-Generation Sequencing Revenue Market Share by Region (2016-2026)
Figure 14. Global Clinical Next-Generation Sequencing Revenue Market Share by Region in 2020
Figure 15. North America Clinical Next-Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Clinical Next-Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Clinical Next-Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Clinical Next-Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Clinical Next-Generation Sequencing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Clinical Next-Generation Sequencing Market Drivers
Figure 21. Clinical Next-Generation Sequencing Market Restraints
Figure 22. Clinical Next-Generation Sequencing Market Trends
Figure 23. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 24. PerkinElmer Recent Developments and Future Plans
Figure 25. Illumina Recent Developments and Future Plans
Figure 26. Beckman Coulter Recent Developments and Future Plans
Figure 27. GATC Biotech Recent Developments and Future Plans
Figure 28. Qiagen Recent Developments and Future Plans
Figure 29. Global Clinical Next-Generation Sequencing Revenue Share by Players in 2020
Figure 30. Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 31. Global Top 3 Players Clinical Next-Generation Sequencing Revenue Market Share in 2020
Figure 32. Global Top 10 Players Clinical Next-Generation Sequencing Revenue Market Share in 2020
Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 34. Global Clinical Next-Generation Sequencing Revenue Share by Type in 2020
Figure 35. Global Clinical Next-Generation Sequencing Market Share Forecast by Type (2021-2026)
Figure 36. Global Clinical Next-Generation Sequencing Revenue Share by Application in 2020
Figure 37. Global Clinical Next-Generation Sequencing Market Share Forecast by Application (2021-2026)
Figure 38. North America Clinical Next-Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 39. North America Clinical Next-Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 40. North America Clinical Next-Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 41. United States Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe Clinical Next-Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 45. Europe Clinical Next-Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 46. Europe Clinical Next-Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 47. Germany Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Clinical Next-Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 53. Asia-Pacific Clinical Next-Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Clinical Next-Generation Sequencing Revenue Market Share by Region (2016-2026)
Figure 55. China Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Japan Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. South Korea Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. India Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Southeast Asia Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Australia Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South America Clinical Next-Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 62. South America Clinical Next-Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 63. South America Clinical Next-Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 64. Brazil Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Argentina Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Middle East and Africa Clinical Next-Generation Sequencing Sales Market Share by Type (2016-2026)
Figure 67. Middle East and Africa Clinical Next-Generation Sequencing Sales Market Share by Application (2016-2026)
Figure 68. Middle East and Africa Clinical Next-Generation Sequencing Revenue Market Share by Country (2016-2026)
Figure 69. Turkey Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Saudi Arabia Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. UAE Clinical Next-Generation Sequencing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Methodology
Figure 73. Research Process and Data Source
Buy
